Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
18.36
Dollar change
-0.47
Percentage change
-2.50
%
IndexRUT P/E- EPS (ttm)-2.21 Insider Own9.27% Shs Outstand27.08M Perf Week2.57%
Market Cap497.32M Forward P/E- EPS next Y-1.98 Insider Trans-2.26% Shs Float24.58M Perf Month-6.45%
Income-59.51M PEG- EPS next Q-0.56 Inst Own88.47% Short Float18.24% Perf Quarter-12.49%
Sales145.60M P/S3.42 EPS this Y-144.71% Inst Trans-3.55% Short Ratio11.36 Perf Half Y-43.26%
Book/sh9.67 P/B1.90 EPS next Y18.91% ROA-14.37% Short Interest4.48M Perf Year-22.82%
Cash/sh10.79 P/C1.70 EPS next 5Y- ROE-21.96% 52W Range14.93 - 45.00 Perf YTD-41.77%
Dividend Est.- P/FCF- EPS past 5Y12.40% ROI-20.67% 52W High-59.20% Beta2.63
Dividend TTM- Quick Ratio4.76 Sales past 5Y310.16% Gross Margin97.58% 52W Low22.97% ATR (14)1.35
Dividend Ex-Date- Current Ratio4.76 EPS Y/Y TTM-159.03% Oper. Margin-20.91% RSI (14)50.14 Volatility8.04% 8.19%
Employees180 Debt/Eq0.11 Sales Y/Y TTM-50.30% Profit Margin-40.87% Recom1.00 Target Price79.47
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q58.21% Payout- Rel Volume0.67 Prev Close18.83
Sales Surprise13.89% EPS Surprise78.62% Sales Q/Q-10.52% EarningsNov 07 AMC Avg Volume394.90K Price18.36
SMA203.19% SMA50-5.79% SMA200-27.87% Trades Volume264,352 Change-2.50%
Date Action Analyst Rating Change Price Target Change
Aug-12-24Initiated Leerink Partners Outperform $70
Dec-13-23Initiated Canaccord Genuity Buy $90
Jul-24-23Initiated William Blair Outperform $71
May-11-23Upgrade H.C. Wainwright Neutral → Buy $19 → $51
Nov-14-22Resumed Wells Fargo Overweight $35
Nov-10-22Downgrade Robert W. Baird Neutral → Underperform $18
Nov-03-22Upgrade Citigroup Neutral → Buy $22 → $35
Nov-02-22Upgrade Barclays Underweight → Equal Weight $16 → $25
Aug-10-22Downgrade Raymond James Mkt Perform → Underperform
Jul-19-22Resumed Cantor Fitzgerald Overweight $86 → $39
Nov-26-24 04:01PM
Nov-18-24 08:00PM
Nov-14-24 01:00AM
Nov-11-24 04:01PM
Nov-08-24 12:15PM
02:29AM Loading…
02:29AM
Nov-07-24 05:55PM
04:48PM
04:01PM
Nov-06-24 07:35AM
Oct-31-24 04:01PM
Oct-30-24 12:00PM
Oct-23-24 04:00AM
Sep-30-24 11:12AM
08:00AM
08:15AM Loading…
Sep-13-24 08:15AM
Sep-08-24 04:51PM
11:49AM
Sep-03-24 08:30AM
Sep-02-24 09:55AM
Aug-27-24 05:00PM
Aug-23-24 12:00PM
Aug-05-24 08:59PM
05:10PM
04:07PM
04:01PM
Aug-01-24 04:01PM
Jul-18-24 07:30PM
Jul-01-24 04:01PM
Jun-20-24 08:00AM
02:49AM Loading…
Jun-15-24 02:49AM
Jun-07-24 10:30AM
Jun-04-24 07:00PM
May-28-24 06:30AM
May-22-24 07:00AM
May-20-24 08:30AM
May-15-24 04:01PM
May-09-24 11:13AM
03:48AM
May-08-24 09:58PM
04:43PM
04:01PM
May-01-24 10:01AM
Apr-25-24 04:01PM
Mar-28-24 01:34AM
Mar-22-24 01:26AM
Mar-09-24 01:09PM
Mar-08-24 12:10PM
06:54AM
Mar-07-24 10:42PM
05:10PM
04:21PM
04:01PM
Mar-04-24 01:23PM
Feb-26-24 03:20PM
09:00AM
Feb-22-24 08:30AM
Feb-21-24 01:04PM
Feb-20-24 04:39PM
09:00AM
Feb-05-24 08:30AM
Jan-23-24 04:16AM
Jan-05-24 01:17PM
Dec-21-23 08:00AM
Dec-17-23 12:03PM
Dec-13-23 10:39PM
Dec-08-23 10:13AM
Dec-04-23 08:30AM
Nov-28-23 08:05AM
07:56AM
Nov-27-23 08:30AM
Nov-15-23 01:26PM
11:30AM
Nov-14-23 05:19PM
04:13PM
04:01PM
10:56AM
Oct-25-23 04:01PM
Oct-23-23 04:01PM
Oct-04-23 11:01PM
08:30AM
Sep-26-23 08:30AM
Sep-19-23 08:30AM
Sep-05-23 08:30AM
Aug-17-23 08:30AM
Aug-14-23 09:00AM
Aug-10-23 07:15AM
Aug-08-23 02:39PM
01:09PM
08:43AM
07:39AM
Aug-07-23 07:50PM
06:43PM
04:01PM
Aug-04-23 09:21AM
Jul-28-23 05:14PM
Jul-24-23 04:01PM
Jul-18-23 06:22AM
Jul-16-23 08:18PM
Jul-14-23 02:36PM
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chivukula PadChief Scientific Officer & COOOct 15 '24Sale20.7612,000249,121435,334Oct 16 09:05 PM
Chivukula PadOfficerOct 15 '24Proposed Sale20.7612,000249,121Oct 15 04:29 PM
Marantz Jing L.DirectorJun 14 '24Option Exercise0.003,13103,131Jun 18 09:01 PM
HOLMES EDWARD WDirectorJun 14 '24Option Exercise0.003,13103,131Jun 18 09:01 PM
Markels JohnDirectorJun 14 '24Option Exercise0.003,13103,131Jun 18 09:00 PM
Marquet MagdaDirectorJun 14 '24Option Exercise0.003,13103,131Jun 18 09:00 PM
BARLOW JAMES FDirectorJun 14 '24Option Exercise0.003,131013,131Jun 18 09:00 PM
FARRELL PETER CDirectorJun 14 '24Option Exercise0.003,131055,741Jun 18 09:00 PM
SASSINE ANDYChief Financial OfficerJun 12 '24Sale32.0350,0001,601,500220,526Jun 14 04:06 PM
Chivukula PadChief Scientific Officer & COOJun 05 '24Sale45.001145,130447,334Jun 07 05:01 PM
Chivukula PadChief Scientific Officer & COOJun 03 '24Sale40.0126,0001,040,234447,448Jun 04 04:05 PM
Chivukula PadChief Scientific Officer & COOMar 25 '24Sale35.0217,435610,574473,448Mar 27 04:15 PM
Chivukula PadChief Scientific Officer & COOMar 19 '24Sale35.018,565299,839490,883Mar 21 05:27 PM